NutriBand Inc. (NTRB) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.
the bull case· 1
16
managers reporting a position in institutional filings
13fJun 30 '26the bear case· 3
4
managers whose positions together concentrate reported value among few holders
13fJun 30 '264 of 13
largest reporting managers cut their stake in the latest quarter
13fJun 30 '26−2.82%
change in shares held by the largest reporting managers over the latest quarter
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Dec 10 '26 report. Not a forecast, not advice.
NutriBand Inc. has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies, from each company's own filings. Largest first.
NTRB (NutriBand Inc.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
tall tick = annual report · 1 on record
High 8.23 at 5:30 pm ET, low 7.16 at 11:30 am ET.
NutriBand Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies
16 managers report a position worth $1.1M between them, and 4 of them hold 80% of it.